Elastrin Therapeutics is a South Carolina-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare during the last 20 years at Clemson University, in collaboration with Dr. Charles Rice. Our team built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting. More via https://www.youtube.com/watch?v=cLUYwR7IEU0
Location: United States, South Carolina, Simpsonville
Employees: 1-10
Total raised: $10M
Founded date: 2017
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 08.04.2022 | - | $10M | - | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 08.04.2022 | Elastrin Therapeutics Closes $10M Funding Round | Elastrin Therapeutics, a Greenville, SC-based biotechnology company, raised $10M in funding. The ro... | finsmes.co... |
| - | Elastrin Therapeutics | “Elastrin Therapeutics: Reverse Cardiovascular Disease ” | fastfounde... |